Corion Biotech S.r.l.

Corion Biotech S.r.l. is a biotechnology startup based in Italy that is dedicated to developing innovative therapeutic solutions for women's health. Founded in 2012, their technology is centered around a specific cell population derived from the human term placenta, allowing them to create a "Cell Therapy without Cells." This unique approach utilizes placental cell-derived biologicals, eliminating the need for direct administration of living cells to the patient, thus minimizing associated risks while maintaining treatment effectiveness. Corion Biotech's ethical, safe, and effective solution has garnered attention, with their last funding round on 31 July 2020 amounting to €500.00K, backed by LIFTT.